Korro Bio, Inc.
Korro Bio, Inc. (KRRO) Revenue
Annual & quarterly revenue history · segment & region breakdown
KRRO · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsKorro Bio, Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 181.46% year-over-year from $0.01B in FY2025.
Revenue trend
2025 – 2017 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.01B | +$0.00B | +181.46% |
| 2024-12-31 | $0.00B | +$0.00B | — |
| 2023-12-31 | $0.00B | +$0.00B | — |
| 2022-12-31 | $0.00B | -$0.01B | -100.00% |
| 2021-12-31 | $0.01B | -$0.02B | -61.96% |
| 2020-12-31 | $0.04B | +$0.01B | +27.76% |
| 2019-12-31 | $0.03B | +$0.03B | — |
| 2018-12-31 | $0.00B | +$0.00B | — |
| 2017-12-31 | $0.00B | — | — |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Korro Bio, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Korro Bio, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Korro Bio, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
KRRO revenue · 4 questionsKRRO's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 181.46% year-over-year from $0.01B in FY2025.
▸ Source: FMP · Korro Bio, Inc. SEC filings · GAAP · Korro Bio, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026